業績

  • 2020年

    英文総説

    1Hayakawa D, Takahashi F, Mitsuishi Y, Tajima K, Hidayat M, Winardi W, Ihara H, Kanamori K, Matsumoto N, Asao T, Ko R, Shukuya T, Takamochi K, Hayashi T, Suehara Y, Takeda Nakamura I, Ueno T, Kohsaka S, Mano H, Takahashi K. Activation of insulin-like growth factor-1 receptor confers acquired resistance to osimertinib in non-small cell lung cancer with EGFR T790M mutation. Thorac Cancer., 2020 Jan; 11(1):140-149.
    2Hosomi Y, Morita S, Sugawara S, Kato T, Fukuhara T, Gemma A, Takahashi K, Fujita Y, Harada T, Minato K, Takamura K, Hagiwara K, Kobayashi K, Nukiwa T, Inoue A; North-East Japan Study Group. Gefitinib Alone Versus Gefitinib Plus Chemotherapy for Non-Small-Cell Lung Cancer With Mutated Epidermal Growth Factor Receptor: NEJ009 Study. J Clin Oncol., 2020 Jan; 38(2):115-123.
    3Ko Y, Asakawa K, Tobino K, Oguma T, Hirai T, Takada T, Takahashi K, Seyama K; Multicenter Lymphangioleiomyomatosis Sirolimus Trial for Safety Study Group.  Quantitative analysis of computed tomography of the lungs in patients with lymphangioleiomyomatosis treated with sirolimus. Heliyon., 2020 Feb; 6(2):e03345. doi: 10.1016/j.heliyon.
    4Mikawa R, Sato T, Suzuki Y, Baskoro H, Kawaguchi K, Sugimoto M. p19Arf exacerbates cigarette smoke-induced pulmonary dysfunction. Biomolecules., 2020 Mar; 10(3):462.
    5Shukuya T, Oyanagi J, Serizawa M, Watanabe M, Yamamoto N, Koh Y. Hypoxia Inducible Factor-1α Inhibition in Von Hippel Lindau-mutant Malignant Pleural Mesothelioma Cells. Anticancer Res., 2020 Apr; 40(4):1867-1874.
    6Tateishi K, Ko R, Shukuya T, Okuma Y, Watanabe S, Kuyama S, Murase K, Tsukita Y, Ashinuma H, Nakagawa T, Uematsu K, Nakao M, Mori Y, Kaira K, Mouri A, Miyabayashi T, Sakashita H, Matsumoto Y, Tanigawa T, Koizumi T, Morita S, Kobayashi K, Nukiwa T, Takahashi K; North East Japan Study Group. Clinical Outcomes of Second-Line Chemotherapy in Patients with Previously Treated Advanced Thymic Carcinoma: A Retrospective Analysis of 191 Patients from the NEJ023 Study. Oncologist., 2020 Apr; 25(4): e668-e674.
    7Llabata P, Mitsuishi Y, Choi PS, Cai D, Francis JM, Torres-Diz M, Udeshi ND, Golomb L, Wu Z, Zhou J, Svinkina T, Aguilera-Jimenez E, Liu Y, Carr SA, Sanchez- Cespedes M, Meyerson M, Zhang X. Multi-Omics Analysis Identifies MGA as a Negative Regulator of the MYC Pathway in Lung Adenocarcinoma. Mol Cancer Res., 2020 Apr; 18(4): 574-584.
    8Suzuki K, Seyama K, Ebana H, Kumasaka T, Kuwatsuru R.Quantitative Analysis of Cystic Lung Diseases by Use of Paired Inspiratory and Expiratory CT: Estimation of the Extent of Cyst-Airway Communication and Evaluation of Diagnostic Utility. Radiology: Cardiothoracic Imaging. , 2020 Apr; 2(2): https://doi.org/10.1148/ryct.2020190097
    9Sekine I, Shintani Y, Shukuya T, Takayama K, Inoue A, Okamoto I, Kiura K, Takahashi K, Dosaka-Akita H, Takiguchi Y, Miyaoka E, Okumura M, Yoshino I. A Japanese lung cancer registry study on demographics and treatment modalities in medically treated patients. Cancer Sci., 2020 May; 111(5):1685-1691.
    10Wang K, Verbakel JY, Oke J, Fleming-Nouri A, Brewin J, Roberts N, Harada N, Atsuta R, Takahashi K, Mori K, Fujisawa T, Shirai T, Kawayama T, Inoue H, Lazarus S, Szefler S, Martinez F, Shaw D, Pavord ID, Thomas M. Using fractional exhaled nitric oxide to guide step-down treatment decisions in patients with asthma: a systematic review and individual patient data meta-analysis. Eur Respir J., 2020 May; 55(5):1902150
    11Okamoto S, Suzuki K, Hayashi T, Muraki K, Nagaoka T, Nishino K, Sekimoto Y, Sasaki S, Takahashi K, Seyama K. Transbronchial lung biopsy for the diagnosis of lymphangioleiomyomatosis: the severity of cystic lung destruction assessed by the modified Goddard scoring system as a predictor for establishing the diagnosis. Orphanet J Rare Dis., 2020 May; 15(1):125
    12Hayashi T, Takamochi K, Kohsaka S, Kishikawa S, Suehara Y, Takahashi F, Suzuki K, Saito T. Spontaneous transformation from EGFR/PTEN co-mutated lung adenocarcinoma to small cell carcinoma in lymph node metastasis. Pathol Int., 2020 May; 70(5): 295-299.
    13Kohsaka S, Hayashi T, Nagano M, Ueno T, Kojima S, Kawazu M, Shiraishi Y, Kishikawa S, Suehara Y, Takahashi F, Takahashi K, Suzuki K, Takamochi K, Mano H. Identification of Novel CD74-NRG2αFusion From Comprehensive Profiling of Lung Adenocarcinoma in Japanese Never or Light Smokers. J Thorac Oncol., 2020 Jun; 15(6): 948-961.
    14Kozuki T, Nogami N, Hataji O, Tsunezuka Y, Seki N, Harada T, Fujimoto N, Bessho A, Takamura K, Takahashi K, Satouchi M, Kato T, Shukuya T, Yamashita N, Okamoto H, Shinkai T, Thoracic Oncology Research Group. Open-label, multicenter, randomized phase II study on docetaxel plus bevacizumab or pemetrexed plus bevacizumab for treatment of elderly (aged ≥75 years) patients with previously untreated advanced non-squamous non-small cell lung cancer: TORG1323. Transl Lung Cancer Res., 2020 Jun; 9(3): 459-470.
    15Ishigaki K, Akiyama M, Kanai M, Takahashi A, Kawakami E, Sugishita H, Sakaue S, Matoba N, Low SK, Okada Y, Terao C, Amariuta T, Gazal S, Kochi Y, Horikoshi M, Suzuki K, Ito K, Koyama S, Ozaki K, Niida S, Sakata Y, Sakata Y, Kohno T, Shiraishi K, Momozawa Y, Hirata M, Matsuda K, Ikeda M, Iwata N, Ikegawa S, Kou I, Tanaka T, Nakagawa H, Suzuki A, Hirota T, Tamari M, Chayama K, Miki D, Mori M, Nagayama S, Daigo Y, Miki Y, Katagiri T, Ogawa O, Obara W, Ito H, Yoshida T, Imoto I, Takahashi T, Tanikawa C, Suzuki T, Sinozaki N, Minami S, Yamaguchi H, Asai S, Takahashi Y, Yamaji K, Takahashi K, Fujioka T, Takata R, Yanai H, Masumoto A, Koretsune Y, Kutsumi H, Higashiyama M, Murayama S, Minegishi N, Suzuki K, Tanno K, Shimizu A, Yamaji T, Iwasaki M, Sawada N, Uemura H, Tanaka K, Naito M, Sasaki M, Wakai K, Tsugane S, Yamamoto M, Yamamoto K, Murakami Y, Nakamura Y, Raychaudhuri S, Inazawa J, Yamauchi T, Kadowaki T, Kubo M, Kamatani Y. Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases. Nat Genet., 2020 Jun; 52(7):669-679.
    16Ihara H, Mitsuishi Y, Kato M, Takahashi F, Tajima K, Hayashi T, Hidayat M, Winardi W, Wirawan A, Hayakawa D, Kanamori K, Matsumoto N, Yae T, Sato T, Sasaki S, Takamochi K, Suehara Y, Ogura D, Niwa SI, Suzuki K, Takahashi K. Nintedanib Inhibits Epithelial-Mesenchymal Transition in A549 Alveolar Epithelial Cells Through Regulation of the TGF-β/Smad Pathway. Respir Investig., 2020 Jul; 58(4): 275-284.
    17Sakamoto S, Kataoka K, Kondo Y, Kato M, Okamoto M, Mukae H, Bando M, Suda T, Yatera K, Tanino Y, Kishaba T, Hattori N, Taguchi Y, Saito T, Nishioka Y, Kuwano K, Kishi K, Inase N, Sasaki S, Takizawa H, Johkoh T, Sakai F, Homma S. Diffuse Lung Diseases Research Group of the Ministry of Health, Labour and Welfare, Japan. Pirfenidone plus inhaled N-acetylcysteine for idiopathic pulmonary fibrosis: a randomised trial. Eur Respir J. 2020 Jul 23:2000348.
    18Kobayashi K, Soejima K, Fukunaga K, Shintani Y, Sekine I, Shukuya T, Takayama K, Inoue A, Okamoto I, Kiura K, Takahashi K, Yamamoto N, Takiguchi Y, Miyaoka E, Okumura M, Yoshino I, and on behalf of the Group on behalf of the Japanese Joint Committee of Lung Cancer Registry. Key prognostic factors for EGFR-mutated non-adenocarcinoma lung cancer patients in the Japanese Joint Committee of Lung Cancer Registry Database. Lung Cancer., 2020 Aug; 146: 236-243.
    19Igawa S, Naoki K, Shintani Y, Sekine I, Shukuya T, Takayama K, Inoue A, Okamoto I, Kiura K, Takahashi K, Yamamoto N, Takiguchi Y, Miyaoka E, Okumura M, Yoshino I. Survival and Prognostic Factors in Elderly Patients Receiving Second-line Chemotherapy for Relapsed Small-Cell Lung Cancer: Results from the Japanese Joint Committee of Lung Cancer Registry. Lung Cancer., 2020 Aug; 146: 160-164.
    20Harada N, Harada S, Ito J, Atsuta R, Hori S, Takahashi K. Mobile Health App for Japanese Adult Patients With Asthma: Clinical Observational Study. J Med Internet Res., 2020 Aug; 22(8):e19006.
    21Tanaka K, Morita S, Ando M, Yokoyama T, Nakamura A, Yoshioka H, Ishiguro T, Miura S, Toyozawa R, Oguri T, Daga H, Ko R, Bessho A, Tashihara M, Iwamoto Y, Hirano K, Nakanishi Y, Nakagawa K, Yamamoto N, Okamoto I. A randomized phase 3 study of maintenance therapy with S-1 plus best supportive care versus best supportive care after induction therapy with carboplatin plus S-1 for advanced or relapsed squamous cell carcinoma of the lung (WJOG7512L). Cancer., 2020 Aug; 125: 3648-3656.
    22Tsuboshima K, Kurihara M, Yamanaka T, Watanabe K, Matoba Y, Seyama K. Does a gender have something to do with clinical pictures of primary spontaneous pneumothorax？ Gen Thorac Cardiovasc Surg., 2020 Aug; 68(8): 741-745.
    23Yamauchi M, Nakayama H, Shiota S, Ohshima Y, Terada J, Nishijima T, Kosuga M, Kitamura T, Tachibana N, Oguri T, Shirahama R, Aoki Y, Ishigaki K, Sugie K, Yagi T, Muraki H, Fujita Y, Takatani T, Muro S. Potential patient screening for late-onset Pompe disease in suspected sleep apnea: a rationale and study design for a Prospective Multicenter Observational Cohort Study in Japan (PSSAP-J Study). Sleep Breath. 2020 Aug 18. doi: 10.1007/s11325-020-02170-6. Online ahead of print.
    24Wang K, Verbakel JY, Oke J, Fleming-Nouri A, Harada N, Atsuta R, Fujisawa T, Kawayama T, Inoue H, Lazarus S, Szefler S, Martinez FD, Shaw D, Pavord ID, Thomas M. Using fractional exhaled nitric oxide to guide step-down treatment decisions in asthma: practical considerations. Eur Respir J., 2020 Aug; 56: 2002809.
    25Miyawaki T, Kenmotsu H, Mori K, Miyawaki E, Mamesaya N, Kawamura T, Kobayashi H, Omori S, Wakuda K, Ono A, Naito T, Murakami H, Harada H, Endo M, Ohde Y, Takahashi K, Takahashi T. Association Between Clinical Tumor Burden and Efficacy of Immune Checkpoint Inhibitor Monotherapy for Advanced Non-Small-Cell Lung Cancer. Clin Lung Cancer., 2020 Sep; 21(5): e405-e414.
    26Hayashi T, Kohsaka S, Takamochi K, Hara K, Kishikawa S, Sano K, Takahashi F, Suehara Y, Saito T, Takahashi K, Suzuki K, Yao T. Clinicopathological characteristics of lung adenocarcinoma with compound EGFR mutations. Hum Pathol., 2020 Sep; 103:42-51.
    27Kato Y, Kato M, Ihara H, Hayakawa E, Shibayama K, Miura K, Yamada T, Mitsuishi Y,  Shukuya T, Ito J, Matsunaga T, Sato T, Suzuki K, Takahashi K. Hermansky-Pudlak syndrome-associated pneumothorax with rapid progression of respiratory failure: a case report. BMC Pulm Med., 2020 Oct; 20(1):259.
    28Kishikawa S, Hayashi T, Saito T, Takamochi K, Kohsaka S, Sano K, Sasahara N, Sasa K, Kurihara T, Hara K, Suehara Y, Takahashi F, Suzuki K, Yao T. Diffuse expression of MUC6 defines a distinct clinicopathological subset of pulmonary invasive mucinous adenocarcinoma. Modern Pathology., 2020 Oct; doi: 10.1038/s41379-020-00690-w. Online ahead of print.
    29Takei S, Ihara H, Togo S, Nakamura A, Fujimoto Y, Watanabe J, Kurokawa K, Shibayama K, Sumiyoshi I, Ochi Y, Iwai M, Okabe T, Chonan M, Misawa S, Ohsaka A, Takahashi K. The synergetic effect of Imipenem-clarithromycin combination in the Mycobacteroides abscessus complex. BMC Microbiol., 2020 Oct; 20(1):316.
    30Okuma Y, Ko R, Shukuya T, Tateishi K, Imai H, Iwasawa S, Miyauchi E, Kojima T, Fujita Y, Hino T, Yamanda S, Suzuki T, Fukuizumi A, Sakakibara T, Harada T, Morita S, Kobayashi K, Nukiwa T, Takahashi K; North East Japan Study Group. Prognostic factors for patients with metastatic or recurrent thymic carcinoma receiving palliative-intent chemotherapy. Lung Cancer., 2020 Oct; 148: 122-128.
    31Kato M, Takahashi F, Sato T, Mitsuishi Y, Tajima K, Ihara H, Nurwidya F, Baskoro H, Murakami A, Kobayashi I, Hidayat M, Shimada N, Sasaki S, Mineki R, Fujimura T, Kumasaka T, Niwa S, Takahashi K. Tranilast Inhibits Pulmonary Fibrosis by Suppressing TGFβ/SMAD2 Pathway. Drug Des Devel Ther., 2020 Oct; 14:4593-4603.
    32Sata N, Inoshita A, Suda S, Shiota S, Shiroshita N, Kawana F, Suzuki Y, Matsumoto F, Ikeda K, Kasai T. Clinical, polysomnographic, and cephalometric features of obstructive sleep apnea with AHI over 100. Sleep Breath., 2020 Nov; doi: 10.1007/s11325-020-02241-8. Online ahead of print.
    33Kurokawa K, Harada N, Sasano H, Takahagi H, Takei S, Nakamura A, Kamada K, Yoshida A, Kikuchi K, Takahashi K. Pulmonary infection due to fluoroquinolone-resistant Mycolicibacterium fortuitum: a case report. BMC Infect Dis. 20(1): 866, 2020 Nov
    34Hayashi T, Kohsaka S, Takamochi K, Kishikawa S, Sano K, Hara K, Suehara Y, Takahashi F, Saito T, Suzuki K, Yao T. Histological Characteristics of Lung Adenocarcinoma With Uncommon Actionable Alterations: Special Emphasis on MET exon 14 Skipping Alterations. Histopathology 2020 Nov 29. doi: 10.1111/his.14311. Online ahead of print.
    35Shukuya T, Ghai V, Amann JM, Okimoto T, Shilo K, Kim TK, Wang K, Carbone DP. Circulating MicroRNAs and Extracellular Vesicle-Containing MicroRNAs as Response Biomarkers of Anti-programmed Cell Death Protein 1 or Programmed Death-Ligand 1 Therapy in NSCLC. J Thorac Oncol. 15(11): 1773-1781, 2020 Nov
    36Kogami M, Suzuki S, Nanjo Y, Ikeda K, Tamura N, Sasaki S, Morimoto S. Complication of coronavirus disease 2019 during remission induction therapy against anti-MDA5 antibody-positive dermatomyositis. Rheumatol Adv Pract. 4(2): rkaa068, 2020 Nov
    37Kurata K, Matsumoto H, Jimbo N, Yakushijin K, Yamamoto K, Ito M, Nakamachi Y, Matsuoka H, Saegusa J, Seyama K, Itoh T, Minami H. Lymphoplasmacytic lymphoma in a patient with Birt-Hogg-Dubé syndrome. Int J Hematol. 112(6):864-870, 2020 Dec
    38Miyazaki K, Togo S, Okamoto R, Idiris A, Kumagai H, Miyagi Y. Collective cancer cell invasion in contact with fibroblasts through integrin-α5β1/fibronectin interaction in collagen matrix. Cancer Sci. 111(12): 4381-4392, 2020 Dec
    39Kikuno M, Ueno Y, Shimizu T, Kuriki A, Tateishi Y, Doijiri R, Shimada Y, Takekawa H, Yamaguchi E, Koga M, Kamiya Y, Ihara M, Tsujino A, Hirata K, Toyoda K, Hasegawa Y, Aizawa H, Hattori N, Urabe T; CHALLENGE ESUS/C.S. collaborators、Underlying embolic and pathologic differentiation by cerebral microbleeds in cryptogenic stroke、J Neurol、 2020；267(5)：1482-1490
    40Hasegawa H, Yatomi K, Mitome-Mishima Y, Miyamoto N, Tanaka R, Oishi H, Arai H, Hattori N, Urabe T. Pioglitazone Prevents Hemorrhagic Infarction After Transient Focal Ischemia in Type 2 Diabetes. Neurosci Res. 2020 Dec 11:S0168-0102(20)30481-8. doi: 10.1016/j.neures.2020.09.004.
    41Hattori N. Elsevier/NSR Symposium: The 20th Anniversary of Parkin Discovery-To the Past, the Present, and the Future. Neurosci Res. 2020 Oct;159:1-2. doi: 10.1016/j.neures.2020.11.001. Epub 2020 Nov 6.
    42Kano M, Takanashi M, Oyama G, Yoritaka A, Hatano T, Shiba-Fukushima K, Nagai M, Nishiyama K, Hasegawa K, Inoshita T, Ishikawa KI, Akamatsu W, Imai Y, Bolognin S, Schwamborn JC, Hattori N. Reduced astrocytic reactivity in human brains and midbrain organoids with PRKN mutations. NPJ Parkinsons Dis. 2020 Nov 13;6(1):33. doi: 10.1038/s41531-020-00137-8.
    43Kujirai H, Itaya S, Ono Y, Takahashi M, Inaba A, Shimo Y, Hattori N, OrimoS. A Study for Expanding Application Sites for Rotigotine Transdermal Patch.Parkinsons Dis. 2020 Aug 10;2020:5892163. doi: 10.1155/2020/5892163.
    44Kuriki A, Ueno Y, Kamiya Y, Shimizu T, Doijiri R, Tateishi Y, Kikuno M, Shimada Y, Takekawa H, Yamaguchi E, Koga M, Ihara M, Ono K, Tsujino A, Hirata K, Toyoda K, Hasegawa Y, Hattori N, Urabe T、Atrial Septal Aneurysm may Cause In-Hospital Recurrence of Cryptogenic Stroke、J Atheroscler Thromb、2020
    45Kurita N, Yamashiro K, Kuroki T, Tanaka R, Urabe T, Ueno Y, Miyamoto N, Takanashi M, Shimura H, Inaba T, Yamashiro Y, Nomoto K, Matsumoto S, Takahashi T, Tsuji H, Asahara T, Hattori N. Metabolic endotoxemia promotes neuroinflammation after focal cerebral ischemia. J Cereb Blood Flow Metab. 2020 Dec;40(12):2505-2520, doi: 10.1177/0271678X19899577.
    46Lee SJ, Lee JS, Funayama M, Yoo HS, Lee PH, Hattori N. Reply: ARSA gene variants and Parkinson’s disease. Brain. 2020 Jun 1;143(6):e48. doi:10.1093/brain/awaa136. PMID: 32437537.
    47Li Y, Ikeda A, Yoshino H, Oyama G, Kitani M, Daida K, Hayashida A, Ogaki K, Yoshida K, Kimura T, Nakayama Y, Ito H, Sugeno N, Aoki M, Miyajima H, Kimura K, Ueda N, Watanabe M, Urabe T, Takanashi M, Funayama M, Nishioka K, Hattori N. Clinical characterization of patients with leucine-rich repeat kinase 2 genetic variants in Japan. J Hum Genet. 2020 Sep;65(9):771-781. doi: 10.1038/s10038-020-0772-4. Epub 2020 May 13. PMID: 32398759.
    48Lin CH, Tsai PI, Lin HY, Hattori N, Funayama M, Jeon B, Sato K, Abe K, Mukai Y, Takahashi Y, Li Y, Nishioka K, Yoshino H, Daida K, Chen ML, Cheng J, Huang CY, Tzeng SR, Wu YS, Lai HJ, Tsai HH, Yen RF, Lee NC, Lo WC, Hung YC, Chan CC, Ke YC, Chao CC, Hsieh ST, Farrer M, Wu RM. Mitochondrial UQCRC1 mutations cause autosomal dominant parkinsonism with polyneuropathy. Brain. 2020 Dec 5;143(11):3352-3373. doi: 10.1093/brain/awaa279.
    49Masuzugawa S, Nishioka K, Imai Y, Ogata J, Shojima Y, Li Y, Yoshino H, Hattori N. A novel rare variant of LRRK2 associated with familial Parkinson’s disease: p.R1501W. Parkinsonism Relat Disord. 2020 Jul;76:46-48. doi:10.1016/j.parkreldis.2020.05.035.
    50Miyamoto N, Magami S, Inaba T, Ueno Y, Hira K, Kijima C, Nakajima S, Yamashiro K, Urabe T, Hattori N、The effects of A1/A2 astrocytes on oligodendrocyte linage cells against white matter injury under prolonged cerebral hypoperfusion、Glia, 2020;68(9):1910-1924, doi: 10.1002/glia.23814.
    51Miyamoto N, Ueno Y, Hira K, Kijima C, Nakajima S, Yamashiro K, Hattori N、Characteristics of Clinical Symptoms, Cerebral Images and Stroke Etiology in Vertebro-Basilar Artery Fenestration-Related Infarction、Brain Sci、2020；10(4)：243, doi: 10.3390/brainsci10040243.
    52Miyazaki H, Yamanaka T, Oyama F, Kino Y, Kurosawa M, Yamada-Kurosawa M, Yamano R, Shimogori T, Hattori N, Nukina N. FACS-array-based cell purification yields a specific transcriptome of striatal medium spiny neurons in a murine Huntington disease model. J Biol Chem. 2020 Jul 17;295(29):9768-9785. doi:10.1074/jbc.RA120.012983. Epub 2020 Jun 4. PMID: 32499373; PMCID: PMC7380199.
    53Mori A, Imai Y, Hattori N. Lipids: Key Players That Modulate α-Synuclein Toxicity and Neurodegeneration in Parkinson’s Disease. Int J Mol Sci. 2020 May 7;21(9):3301. doi: 10.3390/ijms21093301.
    54Nakamura R, Misawa K, Tohnai G, Nakatochi M, Furuhashi S, Atsuta N, Hayashi N, Yokoi D, Watanabe H, Watanabe H, Katsuno M, Izumi Y, Kanai K, Hattori N, Morita M, Taniguchi A, Kano O, Oda M, Shibuya K, Kuwabara S, Suzuki N, Aoki M, Ohta Y, Yamashita T, Abe K, Hashimoto R, Aiba I, Okamoto K, Mizoguchi K, Hasegawa K, Okada Y, Ishihara T, Onodera O, Nakashima K, Kaji R, Kamatani Y, Ikegawa S, Momozawa Y, Kubo M, Ishida N, Minegishi N, Nagasaki M, Sobue G. A multi-ethnic meta-analysis identifies novel genes, including ACSL5, associated with amyotrophic lateral sclerosis. Commun Biol. 2020 Sep 23;3(1):526. doi:10.1038/s42003-020-01251-2. PMID: 32968195; PMCID: PMC7511394.
    55Nakano M, Riku Y, Nishioka K, Hasegawa M, Washimi Y, Arahata Y, Takeda A, Horibe K, Yamaoka A, Suzuki K, Tsujimoto M, Li Y, Yoshino H, Hattori N, Akagi A, Miyahara H, Iwasaki Y, Yoshida M. Unclassified four-repeat tauopathy associated with familial parkinsonism and progressive respiratory failure. Acta Neuropathol Commun. 2020 Aug 27;8(1):148. doi: 10.1186/s40478-020-01025-1.
    56Nakatani M, Matsumoto R, Kobayashi K, Hitomi T, Inouchi M, Matsuhashi M, Kinoshita M, Kikuchi T, Yoshida K, Kunieda T, Miyamoto S, Takahashi R, Hattori N, Ikeda A. Electrical cortical stimulations modulate spike and post-spike slow-related high-frequency activities in human epileptic foci. Clin Neurophysiol. 2020 Aug;131(8):1741-1754. doi: 10.1016/j.clinph.2020.03.042.
    57Nishida Y, Takahashi YK, Kanai T, Nose Y, Ishibashi S, Sanjo N, Uzawa A, Oda F, Ozawa Y, Kuwabara S, Noguchi E, Suzuki S, Nakahara J, Suzuki N, Ogawa T, Yokoyama K, Hattori N, Konno S, Fujioka T, Kawaguchi N, Hatanaka Y, Sonoo M, Kaneko J, Ogino M, Nishiyama K, Nomura K, Yokota T. Safety of tapering tacrolimus dose in patients with well-controlled anti-acetylcholine receptor antibody-positive myasthenia gravis. Eur J Neurol. 2020 Jan;27(1):100-104. doi:10.1111/ene.14039. Epub 2019 Aug 8. PubMed PMID: 31309642.
    58Nishioka K, Hashizume Y, Takanashi M, Daida K, Li Y, Yoshino H, Tambasco N, Prontera P, Hattori Y, Ueda A, Watanabe H, Hattori N. Pathological findings in a patient with alpha-synuclein p.A53T and familial Parkinson’s disease. Parkinsonism Relat Disord. 2020 Nov 4;81:183-187. doi:10.1016/j.parkreldis.2020.11.001.
    59Noda K, Ando M, Jo T, Hattori A, Ogaki K, Sugiyama M, Hattori N, Okuma Y. Mesial Frontal Lobe Infarction Presenting as Pisa Syndrome. J Stroke Cerebrovasc Dis. 2020 Aug;29(8):104882. doi: 10.1016/j.jstrokecerebrovasdis.2020.104882. Epub 2020 May 13. PMID: 32417237.
    60Noda S, Sato S, Fukuda T, Tada N, Hattori N. Aging-related motor function and dopaminergic neuronal loss in C57BL/6 mice. Mol Brain. 2020 Mar 23;13(1):46. doi: 10.1186/s13041-020-00585-6. PMID: 32293495; PMCID: PMC7092461.
    61Noda S, Sato S, Fukuda T, Tada N, Uchiyama Y, Tanaka K, Hattori N. Loss of Parkin contributes to mitochondrial turnover and dopaminergic neuronal loss in aged mice. Neurobiol Dis. 2020 Mar;136:104717. doi: 10.1016/j.nbd.2019.104717.
    62Ogawa T, Hatano T, Oyama G, Takanashi M, Taniguchi D, Hattori N. Graphic Summary of Movement Disorders Society Criteria for Progressive Supranuclear Palsy and Multiple Allocations eXtinction Rules. Mov Disord Clin Pract. 2020 Jan 20;7(2):240-242. doi: 10.1002/mdc3.12894. eCollection 2020 Feb. PubMed PMID: 32071951; PubMed Central PMCID: PMC7011808.
    63Ogawa T, Ogaki K, Ishiguro M, Ando M, Yoshida T, Noda K, Hattori N, Okuma Y. Novel GFAP p. Glu206Ala Mutation in Alexander Disease with Decreased Dopamine Transporter Uptake. Mov Disord Clin Pract. 2020 Jul 6;7(6):720-722. doi: 10.1002/mdc3.12998.
    64Oji Y, Hatano T, Ueno SI, Funayama M, Ishikawa KI, Okuzumi A, Noda S, Sato S, Satake W, Toda T, Li Y, Hino-Takai T, Kakuta S, Tsunemi T, Yoshino H, Nishioka K, Hattori T, Mizutani Y, Mutoh T, Yokochi F, Ichinose Y, Koh K, Shindo K, Takiyama Y, Hamaguchi T, Yamada M, Farrer MJ, Uchiyama Y, Akamatsu W, Wu YR, Matsuda J, Hattori N. Variants in saposin D domain of prosaposin gene linked to Parkinson’s disease. Brain. 2020 Apr 1;143(4):1190-1205. doi: 10.1093/brain/awaa064
    65Oyama M, Okada K, Masuda M, Shimizu Y, Yokoyama K, Uzawa A, Kawaguchi N, Ikeguchi R, Hoshino Y, Hatano T, Ozawa Y, Nakahara J, Aizawa H, Kitagawa K, Hattori N, Kuwabara S, Murai H, Suzuki S. Suitable indications of eculizumab for patients with refractory generalized myasthenia gravis. Ther Adv Neurol Disord. 2020 Mar 18;13:1756286420904207. doi: 10.1177/1756286420904207.
    66Saccenti L, Hagiwara A, Andica C, Yokoyama K, Fujita S, Kato S, Maekawa T, Kamagata K, Le Berre A, Hori M, Wada A, Tateishi U, Hattori N, Aoki S. Myelin Measurement Using Quantitative Magnetic Resonance Imaging: A Correlation Study Comparing Various Imaging Techniques in Patients with Multiple Sclerosis. Cells. 2020 Feb 8;9(2):393. doi: 10.3390/cells9020393.
    67Sato S, Noda S, Hattori N. Pathogenic insights to Parkin-linked model mice. Neurosci Res. 2020 Apr 30:S0168-0102(20)30176-0. doi:10.1016/j.neures.2020.03.014. Epub ahead of print. PMID: 32360487.
    68Sekimoto S, Oyama G, Chiba S, Nuermaimaiti M, Sasaki F, Hattori N. Holomedicine: Proof of the Concept of Interactive Three-Dimensional Telemedicine. Mov Disord. 2020 Oct;35(10):1719-1720. doi: 10.1002/mds.28249. Epub 2020 Sep 14. PMID: 32926470.
    69Shiba-Fukushima K, Inoshita T, Sano O, Iwata H, Ishikawa KI, Okano H, Akamatsu W, Imai Y, Hattori N. A Cell-Based High-Throughput Screening Identified Two Compounds that Enhance PINK1-Parkin Signaling. iScience. 2020 May 22;23(5):101048. doi: 10.1016/j.isci.2020.101048. Epub 2020 Apr 11. PMID: 32335362; PMCID: PMC7183160.
    70Shimonaka S, Matsumoto SE, Elahi M, Ishiguro K, Hasegawa M, Hattori N, Motoi Y. Asparagine residue 368 is involved in Alzheimer’s disease tau strain-specific aggregation. J Biol Chem. 2020 Oct 9;295(41):13996-14014. doi:10.1074/jbc.RA120.013271. Epub 2020 Aug 5. PMID: 32759167; PMCID: PMC7549045.
    71Shojima Y, Ueno Y, Tanaka R, Yamashiro K, Miyamoto N, Hira K, Kurita N, Nakajima S, Urabe T, Hattori N、Eicosapentaenoic-to-Arachidonic Acid Ratio Predicts Mortality and Recurrent Vascular Events in Ischemic Stroke Patients、J Atheroscler Thromb、2020；27(9)：969-977. doi: 10.5551/jat.52373.
    72Seo JH, Maki T, Miyamoto N, Choi YK, Chung KK, Hamanaka G, Park JH, Mandeville ET, Takase H, Hayakawa K, Lok J, Gelman IH, Kim KW, Lo EH, Arai K. AKAP12 Supports Blood-Brain Barrier Integrity against Ischemic Stroke. Int J Mol Sci. 2020 Nov 28;21(23):9078.
    73Suda A, Osada T, Ogawa A, Tanaka M, Kamagata K, Aoki S, Hattori N, Konishi S. Functional Organization for Response Inhibition in the Right Inferior Frontal Cortex of Individual Human Brains. Cereb Cortex. 2020 Nov 3;30(12):6325-6335. doi: 10.1093/cercor/bhaa188. PMID: 32666077.
    74Suzuki K, Okuma Y, Uchiyama T, Miyamoto M, Haruyama Y, Kobashi G, Sakakibara  R, Shimo Y, Hatano T, Hattori N, Yamamoto T, Hirano S, Yamamoto T, Kuwabara S, Kaji Y, Fujita H, Kadowaki T, Hirata K. Determinants of Low Body Mass Index in Patients with Parkinson’s Disease: A Multicenter Case-Control Study. J Parkinsons Dis. 2020;10(1):213-221. doi: 10.3233/JPD-191741. PubMed PMID: 31868678.
    75Takeda A, Takahashi R, Tsuboi Y, Nomoto M, Maeda T, Nishimura A, Yoshida K, Hattori N. Randomized, Controlled Study of Opicapone in Japanese Parkinson’s Patients With Motor Fluctuations. Mov Disord. 2020 Oct 19. doi:10.1002/mds.28322. Epub ahead of print. PMID: 33073879.
    76Takeshige-Amano H, Saiki S, Fujimaki M, Ueno SI, Li Y, Hatano T, Ishikawa KI, Oji Y, Mori A, Okuzumi A, Tsunemi T, Daida K, Ishiguro Y, Imamichi Y, Nanmo H, Nojiri S, Funayama M, Hattori N. Shared Metabolic Profile of Caffeine in Parkinsonian Disorders. Mov Disord. 2020 Aug;35(8):1438-1447. doi:10.1002/mds.28068. Epub 2020 May 1. PMID: 32357260; PMCID: PMC7496239.
    77Tanaka R, Yamashiro K, Ogawa T, Oyama G, Nishioka K, Umemura A, Shimo Y, Hattori N. The absence of orthostatic heart rate increase is associated with cognitive impairment in Parkinson’s disease. PLoS One. 2020 Oct 15;15(10):e0240491. doi: 10.1371/journal.pone.0240491. PMID: 33057432; PMCID:PMC7561175.
    78Taniguchi D, Takanashi M, Hatano T, Kishikawa S, Shimonaka S, Motoi Y, YaoT, Hattori N. Astrocytic 3-Repeat Tau Pathologies in Progressive SupranuclearPalsy. J Neuropathol Exp Neurol. 2020 Sep 1;79(9):1015-1018. doi:10.1093/jnen/nlaa073. PMID: 32827028.
    79Tsuboi Y, Hattori N, Yamamoto A, Sasagawa Y, Nomoto M; ME2125-4 Study Group. Long-term safety and efficacy of safinamide as add-on therapy in levodopa-treated Japanese patients with Parkinson’s disease with wearing-off: Results of an open-label study. J Neurol Sci. 2020 Sep 15;416:117012. doi:10.1016/j.jns.2020.117012.
    80Tsunemi T, Ishiguro Y, Yoroisaka A, Valdez C, Miyamoto K, Ishikawa K, Saiki S, Akamatsu W, Hattori N, Krainc D. Astrocytes Protect Human Dopaminergic Neurons from α-Synuclein Accumulation and Propagation. J Neurosci. 2020 Nov 4;40(45):8618-8628. doi: 10.1523/JNEUROSCI.0954-20.2020.
    81Ueno SI, Hatano T, Okuzumi A, Saiki S, Oji Y, Mori A, Koinuma T, Fujimaki M, Takeshige-Amano H, Kondo A, Yoshikawa N, Nojiri T, Kurano M, Yasukawa K, Yatomi Y, Ikeda H, Hattori N. Nonmercaptalbumin as an oxidative stress marker in Parkinson’s and PARK2 disease. Ann Clin Transl Neurol. 2020 Mar;7(3):307-317. doi:10.1002/acn3.50990.
    82Ueno SI, Oyama G, Kanai K, Hatano T, Shimo Y, Hattori N. A Retrospective Imaging Evaluation of Presynaptic Dopaminergic Degeneration in Multiple System Atrophy with Levodopa Induced Dyskinesia. Tremor Other Hyperkinet Mov (N Y). 2020 Jun 15;10:6. doi: 10.5334/tohm.58.
    83Ueno Y, Hira K, Miyamoto N, Kijima C, Inaba T, Hattori N. Pleiotropic Effects of Exosomes as a Therapy for Stroke Recovery. Int J Mol Sci. 2020 Sep 20;21(18):6894. doi: 10.3390/ijms21186894. PMID: 32962207; PMCID: PMC7555640.
    84Watanabe H, Saiki H, Chiu SW, Yamaguchi T, Kashihara K, Tsuboi Y, Nomoto M, Hattori N, Maeda T, Shimo Y; J‐FIRST Group. Real-World Nonmotor Changes in Patients with Parkinson’s Disease and Motor Fluctuations: J-FIRST. Mov Disord Clin Pract. 2020 Apr 11;7(4):431-439. doi: 10.1002/mdc3.12939. PMID: 32373660; PMCID: PMC7197319.
    85Yamaguchi A, Ishikawa KI, Inoshita T, Shiba-Fukushima K, Saiki S, Hatano T, Mori A, Oji Y, Okuzumi A, Li Y, Funayama M, Imai Y, Hattori N, Akamatsu W. Identifying Therapeutic Agents for Amelioration of Mitochondrial Clearance Disorder in Neurons of Familial Parkinson Disease. Stem Cell Reports. 2020 Jun 9;14(6):1060-1075. doi: 10.1016/j.stemcr.2020.04.011. Epub 2020 May 28. PMID:32470327; PMCID: PMC7355139.
    86Yamanaka T, Miyazaki H, Tosaki A, Maity SN, Shimogori T, Hattori N, Nukina N. Gene expression profiling in neuronal cells identifies a different type of transcriptome modulated by NF-Y. Sci Rep. 2020 Dec 10;10(1):21714. doi:10.1038/s41598-020-78682-8. PMID: 33303918; PMCID: PMC7728767.
    87Yamashiro K, Tanaka R, Kurita N, Ueno Y, Miyamoto N, Hira K, Nakajima S, Urabe T, Hattori N. Cerebral Microbleeds and Chronic Kidney Disease in Acute Ischemic Stroke Patients with Atrial Fibrillation. J Stroke Cerebrovasc Dis.2020 Apr;29(4):104650. doi: 10.1016/j.jstrokecerebrovasdis.104650.
    88Yamashita Y, Hatano T, Ogawa T, Daida K, Motoi Y, Hattori N. Steroid-Responsive Parkinsonism Caused by Cerebral Amyloid Angiopathy-Related Inflammation. Mov Disord Clin Pract. 2020 Feb 13;7(3):329-331. doi:10.1002/mdc3.12901.
    89Yamashita Y, Ogawa T, Ogaki K, Kamo H, Sukigara T, Kitahara E, Izawa N, Iwamuro H, Oyama G, Kamagata K, Hatano T, Umemura A, Kosaki R, Kubota M, Shimo Y, Hattori N. Neuroimaging evaluation and successful treatment by using directional deep brain stimulation and levodopa in a patient with GNAO1-associated movement disorder: A case report. J Neurol Sci. 2020 Apr 15;411:116710. doi: 10.1016/j.jns.2020.116710.
    90Yamashita Y, Takahashi Y, Tsunemi T, Shirane S, Nakazato-Taniguchi T, Taniguchi D, Takanashi M, Sasaki M, Komatsu N, Hattori N. Systemic Sclerosis Precedes POEMS Syndrome. Can J Neurol Sci. 2020 Sep 22:1-4. doi:10.1017/cjn.2020.206.
    91Yoritaka A, Shimo Y, Hatano T, Hattori N. Motor/Nonmotor Symptoms and Progression in Patients with Parkinson’s Disease: Prevalence and Risks in a Longitudinal Study. Parkinsons Dis. 2020 Jun 20;2020:2735361. doi:10.1155/2020/2735361.
    92Kazuo Nakajima, Alannah Miranda, David W Craig, Tatyana Shekhtman, Stanislav Kmoch, Anthony Bleyer, Szabolcs Szelinger, Tadafumi Kato, John R Kelsoe. Ntrk1 mutation co-segregating with bipolar disorder and inherited kidney disease in a multiplex family causes defects in neuronal growth and depression-like behavior in mice. Translational Psychiatry, 2020;10(1).
    93Emilie Kristine Bagge, Noriko Fujimori-Tonou, Mie Kubota-Sakashita, Takaoki Kasahara, Tadafumi Kato. Unbiased PCR-free spatio-temporal mapping of the mtDNA mutation spectrum reveals brain region-specific responses to replication instability. BMC Biology, 2020;18(1).
    94Tomoyo Sawada, Thomas E Chater, Yohei Sasagawa, Mika Yoshimura, Noriko Fujimori-Tonou, Kaori Tanaka, Kynon J M Benjamin, Apuã C M Paquola, Jennifer A Erwin, Yukiko Goda, Itoshi Nikaido, Tadafumi Kato. Developmental excitation-inhibition imbalance underlying psychoses revealed by single-cell analyses of discordant twins-derived cerebral organoids. Molecular Psychiatry, 2020;25(11):2695-2711.
    95Seita Yasuda, Hajime Baba, Hitoshi Maeshima, Takahisa Shimano, Megumi Inoue, Tomoya Ichikawa, Hiroko Shukuzawa, Toshihito Suzuki, Heii Arai. Serum levels and mutual correlations of amyloid β in patients with depression. Geriatrics and Gerontology International, 2020;20(2):125-129.
    96Hiroki Yamashita, Eriko Fukushima, Kaori Shimomura, Hitoki Hirose, Ken Nakayama, Narihiro Orimo, Wanyi Mao, Narimasa Katsuta, Shohei Nishimon. Tohru Ohnuma. Use of skin advanced glycation end product levels measured using a simple noninvasive method as a biological marker for the diagnosis of neuropsychiatric diseases. International Journal of Methods in Psychiatric Research, 2020;29(2).
    97S Noda, T Fukuda, N Tada, Y Uchiyama, K Tanaka, N Hattori. Loss of Parkin contributes to mitochondrial turnover and dopaminergic neuronal loss in aged mice. Neurobiol. Dis. 2020; 36: 104717.
    98S Noda, S Sato, T Fukuda, N Tada, N Hattori. Aging-related motor function and dopaminergic neuronal loss in C57BL/6 mice. Mol. Brain. 2020; 13(1): 46.
    99H Maruyama, A Taguchi, M Mikane, H Lu, N Tada, M Ishijima, H Kaneko, M Kawai, S Goto, A Saito, R Ohashi, Y Nishikawa, S Ishii. Low bone mineral density due to secondary hyperparathyroidism in the GlatmTg(CAG-A4GALT) mouse model of Fabry disease. FASEB BioAdv. 2020; 2(6): 365-381.
    100JAO Trejo, I Tanida, C Suzuki, S Kakuta, N Tada, Y Uchiyama. Characterization of starvation-induced autophagy in cerebellar Purkinje cells of pHluorin-mKate2-human LC3B transgenic mice. Sci. Rep, 2020; 10(1): 9643.
    101T Koga, F Sasaki, K Saeki, S Tsuchiya, T Okuno, M Ohba, T Ichiki, S Iwamoto, H Uzawa, K Kitajima, C Meno, E Nakamura, N Tada, Y Fukui, J Kikuta, M Ishii, Y Sugimoto, M Nakao, T Yokomizo. Expression of leukotriene B4 receptor 1 defines functionally distinct DCs that control allergic skin inflammation. Cell. Mol. Immunol. 2020; doi: 10.1038/s41423-020-00559-7.
    102Hasegawa Y, Watanabe H, Ikami Y, Otsuki S, Iijima K, Yagihara N, Izumi D, Minamino T. J point elevation in high precordial leads associated with risk of ventricular fibrillation. Ann Noninvasive Electrocardiol. 2020; e12820.
    103Kubota N, Ozaki K, Hoyano M, Nishida K, Takano T, Okubo T, Kimura S, Yanagawa T, Kashimura T, Minamino T. Long-Term Prognosis of Patients Who Underwent Percutaneous Transvenous Mitral Commissurotomy for Mitral Stenosis. Int Heart J. 2020; 61(6): 1183-1187.
    104Kubota N, Ozaki K, Hakamata T, Ikami Y, Hoyano M, Minamino T. Angioscopic findings of organized thrombosis of iliac vein in patient with chronic thromboembolic pulmonary hypertension. Cardiovasc Interv Ther. 2020 (in press).
    105Kubota N, Ozaki K, Hoyano M, Minamino T. Angioscopic Findings of Deep Vein Thrombosis Treated by Balloon Angioplasty With Catheter-Directed Thrombolysis. Circ J. 2020; 84(12): 2
    106Fujiki S, Iijima K, Okabe M, Niwano S, Tsujita K, Naito S, Ando K, Kusano K, Kato R, Nitta J, Miura T, Mitsuhashi T, Kario K, Kondo Y, Ieda M, Hagiwara N, Murohara T, Takahashi K, Tomita H, Takeishi Y, Anzai T, Shimizu W, Watanabe M, Morino Y, Kato T, Tada H, Nakagawa Y, Yano M, Maemura K, Kimura T, Yoshida H, Ota K, Tanaka T, Kitamura N, Node K, Aizawa Y, Shimizu I, Izumi D, Ozaki K, Minamino T; EMPA-ICD investigators. Placebo-Controlled, Double-Blind Study of Empagliflozin (EMPA) and Implantable Cardioverter-Defibrillator (EMPA-ICD) in Patients with Type 2 Diabetes (T2DM): Rationale and Design. Diabetes Ther. 2020; 11(11): 2739-2755.
    107Shirakawa K, Endo J, Kataoka M, Katsumata Y, Anzai A, Moriyama H, Kitakata H, Hiraide T, Ko S, Goto S, Ichihara G, Fukuda K, Minamino T, Sano M. MerTK Expression and ERK Activation Are Essential for the Functional Maturation of Osteopontin-Producing Reparative Macrophages After Myocardial Infarction. J Am Heart Assoc. 2020; 9(18): e017071.
    108Kim HK, Ko TH, Song IS, Jeong YJ, Heo HJ, Jeong SH, Kim M, Park NM, Seo DY, Kha PT, Kim SW, Lee SR, Cho SW, Won JC, Youm JB, Ko KS, Rhee BD, Kim N, Cho KI, Shimizu I, Minamino T, Ha NC, Park YS, Nilius B, Han J. BH4 activates CaMKK2 and rescues the cardiomyopathic phenotype in rodent models of diabetes. Life Sci Alliance. 2020; 3(9):e201900619.
    109Sakai R, Ozaki K, Yamaguchi Y, Kubota N, Takano T, Okubo T, Kimura S, Hoyano M, Yanagawa T, Kashimura T, Minamino T. Pulmonary Artery Sarcoma Diagnosed Using an Endovascular Catheter Forceps Biopsy. Intern Med. 2020; 59(17): 2149-2153.
    110Tahara N, Dobashi H, Fukuda K, Funauchi M, Hatano M, Ikeda S, Joho S, Kihara Y, Kondo T, Matsushita M, Minamino T, Nakanishi N, Okano Y, Ozaki Y, Saji T, Sakai S, Tanabe N, Watanabe H, Yamada H, Yoshioka K, Hatta M, Sasayama S. Long-term treatment of pulmonary arterial hypertension with macitentan in Japanese patients. Curr Med Res Opin. 2020; 36(6): 921-928.
    111Takano T, Ozaki K, Hoyano M, Yanagawa T, Kashimura T, Minamino T. Angioscopic findings during balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension Cardiovasc Interv Ther. 2020; 35(4): 421-422.
    112Shimizu I, Minamino T. Cellular Senescence in Arterial Diseases. J Lipid Atheroscler. 2020; 9: 79-91.
    113Otsuki S, Izumi D, Hasegawa Y, Yagihara N, Iijima K, Minamino T. Suppression of cardiac memory-related severe form of torsades de pointes by landiolol in a patient with congenital long QT syndrome type 2. Heart Rhythm Case Rep. 2020; 6(7): 407-410.
    114Kubota H, Endo H, Ishii H, Tsuchiya H, Inaba Y, Terakawa K, Takahashi Y, Noma M, Takemoto K, Taniai S, Sakata K, Soejima K, Shimoyamada H, Kamma H, Kawakami H, Kaneko Y, Hirono S, Izumi D, Ozaki K, Minamino T, Yoshino H, Sudo K. Adult ALCAPA: from histological picture to clinical features. J Cardiothorac Surg 2020; 15: 14.
    115Endo H, Dohi T, Miyauchi K, Takahashi D, Funamizu T, Shitara J, Wada H, Doi S, Kato Y, Okai I, Iwata H, Okazaki S, Isoda K, Daida H. Clinical impact of complex percutaneous coronary intervention in patients with coronary artery disease. Cardiovasc Interv Ther. 2020; 35: 234-241.
    116Fukase T, Dohi T, Kato Y, Chikata Y, Takahashi N, Endo H, Doi S, Nishiyama H, Okai I, Iwata H, Okazaki S, Isoda K, Miyauchi K, Daida H, Minamino T. Long-term clinical outcomes and cause of death after endovascular treatment for femoropopliteal artery lesions. J Cardiol. 2020; 5087: 30367-1.
    117Takahashi N, Dohi T, Funamizu T, Endo H, Wada H, Doi S, Kato Y, Ogita M, Okai I, Iwata H, Okazaki S, Isoda K, Miyauchi K, Shimada K. Prognostic impact of lipoprotein (a) on long-term clinical outcomes in diabetic patients on statin treatment after percutaneous coronary intervention. J Cardiol. 2020; 76: 25-29.
    118Takano AM, Iwata H, Miyosawa K, Kimura A, Mukaida H, Osawa S, Kubota K, Doi S, Funamizu T, Takasu K, Okai I, Tamura H, Isoda K, Okazaki S, Suwa S, Miyauchi K, Sumiyoshi M, Amano A, Daida H. Reduced Number of Platelets During Intra-Aortic Balloon Pumping Counterpulsation Predicts Higher Cardiovascular Mortality After Device Removal in Association with Systemic Inflammation. Int Heart J. 2020; 61: 89-95.
    119Wada H, Dohi T, Miyauchi K, Nishio R, Takeuchi M, Takahashi N, Endo H, Ogita M, Iwata H, Kasai T, Okazaki S, Isoda K, Suwa S, Daida H. Neutrophil to Lymphocyte Ratio and Long-Term Cardiovascular Outcomes in Coronary Artery Disease Patients with Low High-Sensitivity C-Reactive Protein Level. Int Heart J. 2020; 61: 447-453.
    120Chikata Y, Iwata H, Doi S, Funamizu T, Okazaki S, Dohi S, Higuchi R, Saji M, Takamisawa I, Tamura H, Amano A, Daida H, Minamino T. Simultaneous Estimation of Gender Male and Atrial Fibrillation as Risk Factors for Adverse Outcomes Following Transcatheter Aortic Valve Implantation. J Clin Med. 2020; 9: 3963.
    121Takahashi N, Dohi T, Endo H, Funamizu T, Wada H, Doi S, Kato Y, Ogita M, Okai I, Iwata H, Okazaki S, Isoda K, Miyauchi K, Shimada K. Residual Inflammation Indicated by High-Sensitivity C-Reactive Protein Predicts Worse Long-Term Clinical Outcomes in Japanese Patients after Percutaneous Coronary Intervention. J Clin Med. 2020; 9: 1033.
    122Funamizu T, Iwata H, Nishida Y, Miyosawa K, Doi S, Chikata Y, Shitara J, Endo H, Wada H, Naito R, Ogita M, Dohi T, Kasai T, Okazaki S, Isoda K, Miyauchi K, Daida H. Increased risk of cardiovascular mortality by strict glycemic control (pre-procedural HbA1c < 6.5%) in Japanese medically-treated diabetic patients following percutaneous coronary intervention: a 10-year follow-up study. Cardiovasc Diabetol. 2020; 19: 21.
    123Miyosawa K, Iwata H, Minami-Takano A, Hayashi H, Tabuchi H, Sekita G, Kadoguchi T, Ishii K, Nozaki Y, Funamizu T, Chikata Y, Matsushita S, Amano A, Sumiyoshi M, Nakazato Y, Daida H, Minamino T. Enhanced monocyte migratory activity in the pathogenesis of structural remodeling in atrial fibrillation. PLoS One. 2020; 15: e0240540.
    124Hiki M, Iwata H, Takasu K, Nojiri S, Ishikawa G, Chikata Y, C Mattson P, Kasai T, Miyazaki T, Inoue K, Fujiwara Y, Sumiyoshi M, Kinugawa K, Daida H. Elevated Heart Rate in Combination with Elevated Blood Pressure Predicts Lower Cardiovascular Mortality in Acute Decompensated Heart Failure. Int Heart J. 2020; 61: 308-315.
    125Konishi H, Miyauchi K, Onishi A, Suzuki S, Fuchimoto D, Shitara J, Endo H, Wada H, Doi S, Naito R, Ogita M, Dohi T, Kasai T, Daida H. Effect of pemafibrate (K-877), a novel selective peroxisome proliferator-activated receptor α modular (SPPARMα), in atherosclerosis model using low density lipoprotein receptor knock-out swine with balloon injury. PLoS One. 2020; 15: e0241195.
    126Tanaka S, Kamiya K, Saito H, Saito K, Ogasahara Y, Maekawa E, Konishi M, Kitai T, Iwata K, Jujo K, Wada H, Kasai T, Hamazaki N, Nozaki K, Nagamatsu H, Ozawa T, Izawa K, Yamamoto S, Aizawa N, Wakaume K, Oka K, Momomura SI, Kagiyama N, Matsue Y. Prevalence and prognostic value of the coexistence of anemia and frailty in older patients with heart failure: insights from FRAGILE-HF cohort study. ESC Heart Fail. 2020; 8: 625-633.
    127Saito H, Yamashita M, Endo Y, Mizukami A, Yoshioka K, Hashimoto T, Koseki S, Shimode Y, Kitai T, Maekawa E, Kasai T, Kamiya K, Matsue Y. Cognitive impairment measured by Mini-Cog provides additive prognostic information in elderly patients with heart failure. J Cardiol. 2020; 76: 350-356.
    128Matsue Y, Kamiya K, Saito H, Saito K, Ogasahara Y, Maekawa E, Konishi M, Kitai T, Iwata K, Jujo K, Wada H, Kasai T, Nagamatsu H, Ozawa T, Izawa K, Yamamoto S, Aizawa N, Yonezawa R, Oka K, Momomura SI, Kagiyama N. Prevalence and prognostic impact of the coexistence of multiple frailty domains in elderly patients with heart failure: The FRAGILE-HF cohort study. Eur J Heart Fail. 2020; 22: 2112-2119.
    129Ishiwata S, Yatsu S, Kasai T, Sato A, Matsumoto H, Shitara J, Shimizu M, Murata A, Kato T, Suda S, Doi S, Hiki M, Matsue Y, Naito R, Iwata H, Takagi A, Daida H. Prognostic effect of a novel simply calculated nutritional index in acute decompensated heart failure. Nutrients. 2020; 12: E3311.
    130Kimura Y, Kasai T, Tomita Y, Kasagi S, Takaya H, Kato M, Kawana F, Narui K. Relationship between metabolic syndrome and hypercapnia among obese patients with sleep apnea. World J Respirol. 2020; 10: 1-10.
    131Sai E, Shimada K, Aikawa T, Aoshima C, Takamura K, Hiki M, Yokoyama T, Miyazaki T, Fujmoto S, Konishi H, Hirano KI, Daida H, Minamino T. Triglyceride Deposit Cardiomyovasculopathy with Massive Myocardial Triglyceride which was Proven Using Proton-magnetic Resonance Spectroscopy. T.Intern Med. 2020; 6126-20.
    132Kadoguchi T, Shimada K, Miyazaki T, Kitamura K, Kunimoto M, Aikawa T, Sugita Y, Ouchi S, Shiozawa T, Yokoyama-Nishitani M, Fukao K, Miyosawa K, Isoda K, Daida H. Promotion of oxidative stress is associated with mitochondrial dysfunction and muscle atrophy in aging mice. Geriatr Gerontol Int. 2020; 20: 78-84.
    133Endo H, Dohi T, Miyauchi K, Takahashi D, Funamizu T, Shitara J, Wada H, Doi S, Kato Y, Okai I, Iwata H, Okazaki S, Isoda K, Daida H. Clinical impact of complex percutaneous coronary intervention in patients with coronary artery disease. Cardiovasc Interv Ther. 2020; 35: 234-241.
    134Wada H, Dohi T, Miyauchi K, Nishio R, Takeuchi M, Takahashi N, Endo H, Ogita M, Iwata H, Kasai T, Okazaki S, Isoda K, Suwa S, Daida H. Neutrophil to Lymphocyte Ratio and Long-Term Cardiovascular Outcomes in Coronary Artery Disease Patients with Low High-Sensitivity C-Reactive Protein Level. Int Heart J. 2020; 61: 447-453.
    135Long-term clinical outcomes and cause of death after endovascular treatment for femoropopliteal artery lesions. Fukase T, Dohi T, Kato Y, Chikata Y, Takahashi N, Endo H, Doi S, Nishiyama H, Okai I, Iwata H, Okazaki S, Isoda K, Miyauchi K, Daida H, Minamino T. J Cardiol. 2020: S0914-5087: 30367-1.
    136Kato Y, Dohi T, Chikata Y, Fukase T, Takeuchi M, Takahashi N, Endo H, Nishiyama H, Doi S, Okai I, Iwata H, Isoda K, Okazaki S, Miyauchi K, Daida H, Minamino T. Predictors of discordance between fractional flow reserve and resting full-cycle ratio in patients with coronary artery disease: Evidence from clinical practice. J Cardiol. 2020: S0914-5087: 30352-X.
    137Shiraishi Y, Kohsaka S, Katsuki T, Harada K, Miyazaki T, Miyamoto T, Matsushita K, Iida K, Takei M, Yamamoto Y, Shindo A, Kitano D, Nagatomo Y, Jimba T, Yamamoto T, Nagao K, Takayama M; for Tokyo CCU Network Scientific Committee: Benefit and harm of intravenous vasodilators across the clinical profile spectrum in acute cardiogenic pulmonary oedema patients. Eur Heart J Acute Cardiovasc Care. 2020;9:448-458.
    138Shimada K, Morinaga H, Kiyanagi T, Miyazaki T, Nishitani-Yokoyama M, Okai I, Tamura H, Konishi H, Kurata T, Miyauchi K, Daida H: Safety and Efficacy of Simultaneous Inoculations of Pneumococcal and Influenza Vaccines in Patients with Coronary Artery Disease. J Atheroscler Thromb. 2020 Oct 15. Online ahead of print.
    139Wada H, Dohi T, Miyauchi K, Takahashi N, Nishio R, Takeuchi M, Takahashi N, Endo H, Ogita M, Iwata H, Kasai T, Okazaki S, Isoda K, Suwa S, Daida H. Neutrophil to lymphocyte ratio and long-term cardiovascular outcomes in coronary artery disease patients with low high-sensitivity C-reactive protein level. Int Heart J. 2020 May 30;61(3):447-453.
    140Sato-Okabayashi Y, Isoda K, Heissig B, Kadoguchi T, Akita K, Kitamura K, Shimada K, Hattori K, Daida H . Low-dose oral cyclophosphamide therapy reduces atherosclerosis progression by decreasing inflammatory cells in a murine model of atherosclerosis.Int J Cardiol Heart Vasc. 2020 May 10;28:100529.
    141Al Shahi H, Kadoguchi T, Shimada K, Fukao K, Matsushita S, Aikawa T, Ouchi S, Shiozawa T, Takahashi S, Sato-Okabayashi Y, Akita K, Isoda K, Miyazaki T, Daida H. Voluntary exercise and cardiac remodeling in a myocardial infarction model.  Open Medicine 2020; 15: 545–555.
    142Nakada S, Yamashita Y, Machida S, Miyagoe-Suzuki Y, Arikawa-Hirasawa E Perlecan facilitates neuronal nitric oxide synthase delocalization in denervation-Induced muscle atrophy Cells. 2020 Nov 23;9(11):2524 doi: 10.3390/cells9112524
    143Fujimoto U., Ogawa A., Osada T., Tanaka M., Suda A., Hattori N., Kamagata K., Aoki S., Konishi S. Network centrality reveals dissociable brain activity during response inhibition in human right inferior frontal cortex. Neuroscience, 433, 163-173, 2020
    144Tanaka M., Osada T., Ogawa A., Kamagata K., Aoki S., Konishi S. Dissociable networks of the lateral/medial mammillary body in human brain. Frontiers in Human Neuroscience, 14, 228, 2020
    145Ogawa A., Osada T., Tanaka M., Kamagata K., Aoki S., Konishi S. Connectivity-based localization of human hypothalamic nuclei in functional images of standard voxel size. Neuroimage, 221, 117205, 2020
    146Suda A., Osada, T., Ogawa,A., Tanaka M., Kamagata K., Aoki S., Hattori N., Konishi S. Functional organization for response inhibition in the right inferior frontal cortex of individual human brains. Cereb Cortex, 30, 6325-6335, 2020
    147Mario Suzuki, Akihide Kondo, Ikuko Ogino, Osamu Akiyama, Naohide Fujita, Yuzaburo Shimizu, Hajime Arai ,A case of solitary subependymal giant cell astrocytoma with histopathological anaplasia and TSC2 gene alteration:Childs Nerv Syst . 2020 Jul 29.
    148Akihide Kondo, Osamu Akiyama, Shigeki Aoki, Hajime Arai ,Application of intra-operative magnetic resonance imaging for intracranial epidermoid cysts:Br J Neurosurg . 2020 Jun 26;1-5.
    149Chihiro Kamohara, Madoka Nakajima, Kaito Kawamura, Chihiro Akiba, Ikuko Ogino, Hanbing Xu, Kostadin Karagiozov, Hajime Arai, Masakazu Miyajima,Neuropsychological tests are useful for predicting comorbidities of idiopathic normal pressure hydrocephalus:Acta Neurol Scand; 2020 Dec;142(6):623-631.
    150Hasegawa H, Yatomi K, Mitome-Mishima Y, Miyamoto N, Tanaka R, Oishi H, Arai H, Hattori N, Urabe T:Pioglitazone Prevents Hemorrhagic Infarction After Transient Focal Ischemia in Type 2 Diabetes:Neurosci Res. S0168-0102 (20) 30481-8. 2020
    151Oishi H, Mishima Y, Yatomi K, Teranishi K, Suzuki K, Fujii T:Defective Endothelialization of Pipeline Embolization Device After Flow Diverter Therapy: An Autopsy Case Report.Neurologia medico-chirurgia. in press. 2020
    152Chihiro Kamohara, Madoka Nakajima, Kaito Kawamura, Chihiro Akiba, Ikuko Ogino, Kanei Jo, Meng Wei, Karagiozov, Kostadin, Hajime Arai, Masakazu Miyajima:Neuropsychological tests for predicting comorbidities of idiopathic normal-pressure hydrocephalus. Acta Neurrol Scand, 142(6):623-631.https://doi.org/10.1111/ane.13306. 2020. (IF 2.852)
    153Madoka Nakajima, Tuomas Rauramaa, Petra M Mäkinen, Mikko Hiltunen, Sanna-Kaisa Herukka, Merja Kokki, Tadeusz Musialowicz, Henna-Kaisa Jyrkkänen, Nils Danner, Antti Junkkari, Anne M Koivisto, Juha E Jääskeläinen, Masakazu Miyajima, Ikuko Ogino, Akiko Furuta, Chihiro Akiba, Kaito Kawamura, Chihiro Kamohara, Hidenori Sugano, Yuichi Tange, Kostadin Karagiozov, Ville Leinonen, Hajime Arai:Diagnosis of idiopathic normal pressure hydrocephalus using PTPR type Q concentrations in cerebrospinal fluid: A two-cohort multinational study.Eur J Neurol. doi: 10.1111/ene.14575. 2020 (IF 4.516)
    154Tanida I, Furuta Y, Yamaguchi J, Kakuta S, Oliva Trejo JA, Uchiyama Y (2020) Two-color in-resin CLEM of Epon-embedded cells using osmium resistant green and red fluorescent proteins. Sci Rep, (2020) 10:21871　https://doi.org/10.1038/s41598-020-78879-x
    155Ogawa M, Shirasago Y, Tanida I, Kakuta S, Uchiyama Y, Shimojima M, Hanada K, Saijo M, Fukasawa M (2020) Structural basis of antiviral activity of caffeic acid against severe fever with thrombocytopenia syndrome virus. J Infect Chemother,  S1341-321X820)30374-3. doi:10.1016/j.jiac.2020.10.015.
    156Morimoto K, Suzuki N, Tanida I, Kakuta S, Furuta Y, Uchiyama Y, Hanada K, Suzuki Y, Yamaji T (2020) Blood group P1 antigen-bearing glycoproteins are functional but less efficient receptors of Shiga toxin than conventional glycolipid-based receptors. J Biol Chem, 295(28):9490-9501. doi: 10.1074/jbc.RA120.013926.
    157Yoshino S, Iwasaki Y, Matsumoto S, Satoh T, Ozawa A, Yamada E, Kakizaki S, Oliva Trejo JA, Yasuo Uchiyama3, Masanobu Yamada1 and Masatomo Mori (2020) Administration of small-molecule guanabenz acetate attenuates fatty liver and hyperglycemia associated with obesity. Sci Rep, 13;10(1):13671. doi: 10.1038/s41598-020-70689-5.
    158Tanida I, Kakuta S, Oliva Trejo J, Uchiyama Y (2020) Visualization of cytoplasmic organelles via in-resin CLEM using an osmium-resistant far-red protein. Sci Rep, 10.1038/s41598-020-68191-z
    159Oliva Trejo JA, Tanida I, Suzuki C, Kakuta S, Tada N, Uchiyama Y (2020) Characterization of starvation-induced autophagy in cerebellar Purkinje cells of pHluorin-mKate2-human LC3B transgenic mice. Sci Rep, 10.1038/s41598-020-66370-6
    160Ozawa K, Tsumoto H, Miura Y, Komatsubara AT, Yamaguchi J, Iguchi-Ariga SMM, Sakuma T, Yamamoto T, Uchiyama Y (2020) DJ-1 is indispensable to S-nitrosylation of parkin, which maintains function of mitochondria. Sci Rep, doi: 10.1038/s41598-020-61287-6.
    161Lüningschrör P, Werner G, Stroobants S, Kakuta S, Dombert B, Sinske D, Wanner R, Lüllmann-Rauch R, Wefers B, Wurst W, D’Hooge R, Uchiyama Y, Sendtner M, Haass C, Saftig P, Knöll B, Capell A, Damme M (2020) The FTLD risk factor TMEM106B regulates the transport of lysosomes at the axon initial segment of motoneurons. Cell Rep, 30:3506-3519.e6. doi: 10.1016/j.celrep.2020.02.060.
    162Tanida I, Furuta Y, Yamaguchi J, Kakuta S, Oliva Trejo JA, Uchiyama Y., Two-color in-resin CLEM of Epon-embedded cells using osmium resistant green and red fluorescent proteins., Sci Rep., 2020; 10(1): 21871
    163Tanida I, Kakuta S, Oliva Trejo JA, Uchiyama Y., Visualization of cytoplasmic organelles via in-resin CLEM using an osmium-resistant far-red protein., Sci Rep., 2020; 10(1): 11314.
    164Oliva Trejo JA, Tanida I, Suzuki C, Kakuta S, Tada N, Uchiyama Y., Characterization of starvation-induced autophagy in cerebellar Purkinje cells of pHluorin-mKate2-human LC3B transgenic mice., Sci Rep., 2020; 10(1): 9643
    165Ogawa M, Shirasago Y, Tanida I, Kakuta S, Uchiyama Y, Shimojima M, Hanada K, Saijo M, Fukasawa M., Structural basis of antiviral activity of caffeic acid against severe fever with thrombocytopenia syndrome virus., J Infect Chemother., 2020; S1341-321X(20): 30374-3
    166Morimoto K, Suzuki N, Tanida I, Kakuta S, Furuta Y, Uchiyama Y, Hanada K, Suzuki Y, Yamaji T., Blood group P1 antigen-bearing glycoproteins are functional but less efficient receptors of Shiga toxin than conventional glycolipid-based receptors., J Biol Chem, 2020; 295(28): 9490-9501
    167Ogawa M, Takada N, Shizukuishi S, Tomokiyo M, Chang B, Yoshida M, Kakuta S, Tanida I, Ryo A, Guan JL, Takeyama H, Ohnishi M., Streptococcus pneumoniae triggers hierarchical autophagy through reprogramming of LAPosome-like vesicles via NDP52-delocalization., Commun Biol., 2020; 3(1): 25
    168Oji Y, Hatano T, Ueno SI, Funayama M, Ishikawa KI, Okuzumi A, Noda S, Sato S, Satake W, Toda T, Li Y, Hino-Takai T, Kakuta S, Tsunemi T, Yoshino H, Nishioka K, Hattori T, Mizutani Y, Mutoh T, Yokochi F, Ichinose Y, Koh K, Shindo K, Takiyama Y, Hamaguchi T, Yamada M, Farrer MJ, Uchiyama Y, Akamatsu W, Wu YR, Matsuda J, Hattori N. Variants in saposin D domain of prosaposin gene linked to Parkinson’s disease. Brain, 2020;143,:1190-1205.
    169Takeshige-Amano H, Saiki S, Fujimaki M, Ueno SI, Li Y, Hatano T, Ishikawa KI, Oji Y, Mori A, Okuzumi A, Tsunemi T, Daida K, Ishiguro Y, Imamichi Y, Nanmo H, Nojiri S, Funayama M, Hattori N. Shared Metabolic Profile of Caffeine in Parkinsonian Disorders Mov Disord, 2020;35(8):1438-1447.
    170Li Y, Ikeda A, Yoshino H, Oyama G, Kitani M, Daida K, Hayashida A, Ogaki K, Yoshida K, Kimura T, Nakayama Y, Ito H, Sugeno N, Aoki M, Miyajima H, Kimura K, Ueda N, Watanabe M, Urabe T, Takanashi M, Funayama M, Nishioka N, Hattori N. Clinical characterization of patients with leucine-rich repeat kinase 2 genetic variants in Japan. Journal of human genetics, 2020;65:771-781.
    171Yamaguchi A, Ishikawa KI, Inoshita T, Shiba-Fukushima K, Saiki S, Hatano T, Mori A, Oji Y, Okuzumi A, Li Y, Funayama M, Imai Y, Hattori N, Akamatsu W. Identifying Therapeutic Agents for Amelioration of Mitochondrial Clearance Disorder in Neurons of Familial Parkinson Disease. Stem cell reports, 2020;14:1060-1075.
    172Hayashida A, Li Y, Yoshino H, Daida K, Ikeda A, Ogaki K, Fuse A, Mori A, Takanashi M, Nakahara T, Yoritaka A, Tomizawa Y, Furukawa Y, Kanai K, Nakayama Y, Ito H, Ogino M, Hattori Y, Hattori T, Ichinose Y, Takiyama Y, Saito T, Kimura T, Aizawa H, Shoji H, Mizuno Y, Matsushita T, Sato M, Sekijima Y, Morita M, Iwasaki A, Kusaka H, Tada M, Tanaka F, Sakiyama Y, Fujimoto T, Nagara Y, Kashihara K, Todo H, Nakao K, Tsuruta K, Yoshikawa M, Hara H, Yokote H, Murase N, Nakamagoe K, Tamaoka A, Takamiya M, Morimoto N, Nokura K, Kako T, Funayama M, Nishioka K, Hattori N. The identified clinical features of Parkinson’s disease in homo-, heterozygous and digenic variants of PINK1. Neurobiol Aging, 2020; S0197-4580(20):30210-4.
    173Daida K, Nishioka K, Li Y, Yoshino H, Shimada T, Dougu N, Nakatsuji Y, Ohara S, Hashimoto T, Okiyama R, Yokochi F, Suzuki C, Tomiyama M, Kimura K, Ueda N, Tanaka F, Yamada H, Fujioka S, Tsuboi Y, Uozumi T, Takei T, Matsuzaki S, Shibasaki M, Kashihara K, Kurisaki R, Yamashita T, Fujita N, Hirata Y, Ii Y, Wada C, Eura N, Sugie K, Higuchi Y, Kojima F, Imai H, Noda K, Shimo Y, Funayama M, Hattori N. PLA2G6 variants associated with the number of affected alleles in Parkinson’s disease in Japan. Neurobiol Aging. 2020;S0197-4580(20):30220-7.
    174Lin CH, Tsai PI, Lin HY, Hattori N, Funayama M, Jeon B, Sato K, Abe, K, Mukai Y, Takahashi Y, Li Y, Nishioka K, Yoshino H, Daida K, Chen ML, Cheng J, Huang CY, Tzeng SR, Wu YS, Lai HJ, Tsai HH, Yen RF, Lee NC, Lo WC, Hung YC, Chan CC, Ke YC, Chao CC, Hsieh ST, Farrer MJ, Wu RM. Mitochondrial UQCRC1 mutations cause autosomal dominant parkinsonism. Brain, 2020;143(11):3352-3373.
    175Daida K, Funayama M, Li Y. Yoshino H, Hayashida A, Ikeda A, Ogaki K, Nishioka K, Hattori N. Identification of disease-associated variants by targeted gene panel resequencing in Parkinson’s disease. Front Neurol. 2020;11:576465.
    176R Setsuie, K Tamura, K Miyamoto, T Watanabe, K Takeda, Y Miyashita.  Off-peak 594-nm light surpasses on-peak 532-nm light in silencing distant ArchT-expressing neurons in vivo.  iScience 23, 101276, 2020.
    177Oji Y, Hatano T, Ueno SI, Funayama M, Ishikawa KI, Okuzumi A, Noda S, Sato S, Satake W, Toda T, Li Y, Hino-Takai T, Kakuta S, Tsunemi T, Yoshino H, Nishioka K, Hattori T, Mizutani Y, Mutoh T, Yokochi F, Ichinose Y, Koh K, Shindo K, Takiyama Y, Hamaguchi T, Yamada M, Farrer MJ, Uchiyama Y, Akamatsu W, Wu YR, Matsuda J, Hattori N. Variants in saposin D domain of prosaposin gene linked to Parkinson’s disease. Brain, 2020;143:1190-1205.
    178Masuzugawa S, Nishioka K, Imai Y, Ogata J, Shojima Y, Li Y, Yoshino H, Hattori N.A novel rare variant LRRK2 associated with familial Parkinson’s disease: p.R1501W. Parkinsonism Relat Disord, 2020;76:46-48.
    179Li Y, Ikeda A, Yoshino H, Oyama G, Kitani M, Daida K, Hayashida A,  Ogaki K, Yoshida Y, Kimura T, Nakayama Y, Ito H, Sugeno N, Aoki M, Miyajima H, Kimura K, Ueda N, Watanabe M, Urabe T, Takanashi M, Funayama M, Nishioka K, Hattori N. Clinical characterization of patients with leucine-rich repeat kinase 2 genetic variants in Japan. J Hum Genet, 2020;6:771-781.
    180Daida K, Funayama M, Li Y, Yoshino H, Hayashida A, Ikeda A, Ogaki K, Nishioka K, Hattori N. Identification of disease-associated variants by targeted gene panel resequencing in Parkinson’s disease. Frontiers in Neurology, 2020;11:576465.
    181Nishioka K, Hashizume Y, Takanashi M, Daida K, Li Y, Yoshino H, Tambasco N, Prontera P, Hattori Y, Ueda A, Watanabe H, Hattori N. Pathological findings in a patient with alpha-synuclein p.A53T and familial Parkinson’s disease. Parkinsonism Relat Disord, 2020;81:183-187.
    182Lin CH, Tsai PI, Lin HY, Hattori N, Funayama M, Jeon B, Sato K, Abe K, Mukai Y, Takahashi Y, Li Y, Nishioka K, Yoshino H, Daida K, Chen ML, Cheng J, Huang CY, Tzeng SR, Wu YS, Lai HJ, Tsai HH, Yen RF, Lee NC, Lo WC Hung YC, Chan CC, Ke YC, Chao CC, Hsieh ST, Farrer M, Wu RM. Mitochondrial UQCRC1 mutations cause autosomal dominant parkinsonism with polyneuropathy. Brain, 2020;143:3352-3373.
    183Nakano1 M, Riku Y, Nishioka K, Hasegawa M, Washimi Y, Arahata Y, Takeda A, Horibe K, Yamaoka A, Suzuki K, Tsujimoto M, Li Y, Yoshino H, Hattori N, Akagi A, Miyahara H, Iwasaki Y, Yoshida M. Unclassified four‑repeat tauopathy associated with familial parkinsonism and progressive respiratory failure. Acta Neuropathol Commun, 2020;8:148.
    184Kataura T., Saiki S., Ishikawa K.I., Akamatsu W., Sasazawa Y., Hattori N., Imoto M. BRUP-1, an intracellular bilirubin modulator, exerts neuroprotective activity in a cellular Parkinson’s disease model. J Neurochem 2020;155(1):81-97.
    185Kataura T., Tashiro E., Nishikawa S., Shibahara K., Muraoka Y., Miura M., Sakai S., Katoh N., Totsuka M., Onodera M., Shin-Ya K., Miyamoto K., Sasazawa Y., Hattori N., Saiki S., Imoto M. A chemical genomics-aggrephagy integrated method studying functional analysis of autophagy inducers. Autophagy 2020:1-17.
    186Matoba K, Kotani T, Tsutsumi A, Tsuji T, Mori T, Noshiro D, Sugita Y, Nomura N, Iwata S, Ohsumi Y, Fujimoto T, Nakatogawa H, Kikkawa M, Noda NN. A lipid scramblase mediates autophagosomal membrane expansion. Nat Struct Mol Biol 2020; 27, 1185-1193.
    187Ogasawara Y, Chang J, Tatematsu T, Uchida M, Murase O, Yoshikawa S, Ohsaki Y, Fujimoto T. Long-term autophagy is sustained by activation of CCTβ3 on lipid droplets. Nat Commun 2020; 11, 4480.
    188Masuda T, Hirose H, Baba K, Walrant A, Sagan S, Inagaki N, Fujimoto T, Futaki S. An artificial amphiphilic peptide promotes endocytic uptake by inducing membrane curvature. Bioconjug Chem 2020; 31, 1161-1165.
    189Schäfer J, Schessner JP, Tsuju T, Funaya C, Bircham PW, Schaeff K, Ruffini G, Fujimoto T, Schuck S. ESCRT machinery mediates selective microautophagy of endoplasmic reticulum. EMBO J 2020; 39, e102586.
    190Shirakawa R, Goto-Ito S, Goto K, Wakayama S, Kubo H, Sakata N, Trinh DA, Yamagata A, Sato Y, Masumoto H, Cheng J, Fujimoto T, Fukai S, Horiuchi H. A SNARE geranylgeranyltransferase essential for the organization of the Golgi apparatus. EMBO J 2020; 39, e104120.
    英文総説
    1Okabe T, Togo S, Fujimoto Y, Watanabe J, Sumiyoshi I, Orimo A, Takahashi K. Mesenchymal Characteristics and Predictive Biomarkers on Circulating Tumor Cells for Therapeutic Strategy. Cancers(Basel) 12(12): 3588, 2020 Nov
    2Ueno Y, Hira K, Miyamoto N, Kijima C, Inaba T, Hattori N. Pleiotropic Effects of Exosomes as a Therapy for Stroke Recovery. Int J Mol Sci. 2020 Sep 20;21(18):6894
    3Shimada T, Miyamoto N, Shimada Y, Watanabe M, Shimura H, Ueno Y, Yamashiro K, Hattori N, Urabe T. Analysis of Clinical Symptoms and Brain MRI of Heat Stroke: 2 Case Reports and a Literature Review. J Stroke Cerebrovasc Dis. 2020 Feb;29(2):104511. doi: 10.1016/j.jstrokecerebrovasdis.2019.104511. Epub 2019 Nov 26. Review.
    4Y Miyashita. The History of Neuroscience in Autobiography 11, 228-267, 2020.
    5Ogasawara Y, Tsuji T, Fujimoto T. Multifarious roles of lipid droplets in autophagy – Target, product, and what else? Semin Cell Dev Biol 2020; 108, 47-54.
    6Yamaguchi T, Fujimoto T, Takahashi T. Method for efficient observation of caveolin-1 in plasma membrane by microscopy imaging analysis. Methods Mol Biol 2020; 2169, 43-52.